Brockhaus F - Search Results

1

Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial.

Konstan MW, Geller DE, Minić P, Brockhaus F, Zhang J, Angyalosi G. Konstan MW, et al. Among authors: brockhaus f. Pediatr Pulmonol. 2011 Mar;46(3):230-8. doi: 10.1002/ppul.21356. Epub 2010 Oct 20. Pediatr Pulmonol. 2011. PMID: 20963831 Free PMC article. Clinical Trial.

2

Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial.

Galeva I, Konstan MW, Higgins M, Angyalosi G, Brockhaus F, Piggott S, Thomas K, Chuchalin AG. Galeva I, et al. Among authors: brockhaus f. Curr Med Res Opin. 2013 Aug;29(8):947-56. doi: 10.1185/03007995.2013.805122. Epub 2013 Jun 5. Curr Med Res Opin. 2013. PMID: 23672633 Free PMC article. Clinical Trial.

3

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial.

Konstan MW, Flume PA, Kappler M, Chiron R, Higgins M, Brockhaus F, Zhang J, Angyalosi G, He E, Geller DE. Konstan MW, et al. Among authors: brockhaus f. J Cyst Fibros. 2011 Jan;10(1):54-61. doi: 10.1016/j.jcf.2010.10.003. Epub 2010 Nov 12. J Cyst Fibros. 2011. PMID: 21075062 Free PMC article. Clinical Trial.

4

Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review.

Ratjen F, Brockhaus F, Angyalosi G. Ratjen F, et al. Among authors: brockhaus f. J Cyst Fibros. 2009 Dec;8(6):361-9. doi: 10.1016/j.jcf.2009.08.004. Epub 2009 Sep 10. J Cyst Fibros. 2009. PMID: 19747887 Free article. Review.

5

Fevipiprant, an oral prostaglandin DP₂ receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids.

Bateman ED, Guerreros AG, Brockhaus F, Holzhauer B, Pethe A, Kay RA, Townley RG. Bateman ED, et al. Among authors: brockhaus f. Eur Respir J. 2017 Aug 24;50(2):1700670. doi: 10.1183/13993003.00670-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28838980 Free article. Clinical Trial.

6

Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials.

Brightling CE, Gaga M, Inoue H, Li J, Maspero J, Wenzel S, Maitra S, Lawrence D, Brockhaus F, Lehmann T, Brindicci C, Knorr B, Bleecker ER. Brightling CE, et al. Among authors: brockhaus f. Lancet Respir Med. 2021 Jan;9(1):43-56. doi: 10.1016/S2213-2600(20)30412-4. Epub 2020 Sep 24. Lancet Respir Med. 2021. PMID: 32979986 Clinical Trial.

7

Hampered motility promotes the evolution of wrinkly phenotype in Bacillus subtilis.

Richter A, Hölscher T, Pausch P, Sehrt T, Brockhaus F, Bange G, Kovács ÁT. Richter A, et al. Among authors: brockhaus f. BMC Evol Biol. 2018 Oct 16;18(1):155. doi: 10.1186/s12862-018-1266-2. BMC Evol Biol. 2018. PMID: 30326845 Free PMC article.

8

NO-Evoked macrophage apoptosis is attenuated by cAMP-induced gene expression.

von Knethen A, Brockhaus F, Kleiter I, Brüne B. von Knethen A, et al. Among authors: brockhaus f. Mol Med. 1999 Oct;5(10):672-84. Mol Med. 1999. PMID: 10602776 Free PMC article.

9

p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide.

Brockhaus F, Brüne B. Brockhaus F, et al. Oncogene. 1999 Nov 11;18(47):6403-10. doi: 10.1038/sj.onc.1203058. Oncogene. 1999. PMID: 10597241

10

Overexpression of CuZn superoxide dismutase protects RAW 264.7 macrophages against nitric oxide cytotoxicity.

Brockhaus F, Brüne B. Brockhaus F, et al. Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):295-303. Biochem J. 1999. PMID: 10024504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results